Operating Lease, Right-of-Use Asset of Vor Biopharma Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vor Biopharma Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Vor Biopharma Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,043,000, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vor Biopharma Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,043,000 -$33,253,000 -92% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $24,000* -$37,541,000 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $33,697,000 -$5,119,000 -13% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $35,007,000 -$5,041,000 -13% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $36,296,000 -$4,966,000 -12% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $37,565,000 -$4,889,000 -12% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $38,816,000 -$4,759,000 -11% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $40,048,000 -$4,396,000 -9.9% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $41,262,000 -$4,128,000 -9.1% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $42,454,000 -$3,688,000 -8% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $43,575,000 +$21,978,000 +102% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $44,444,000 +$28,774,000 +184% 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $45,390,000 +$29,374,000 +183% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $46,142,000 +$29,786,000 +182% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $21,597,000 +$4,801,000 +29% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $15,670,000 -$1,447,000 -8.5% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $16,016,000 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $16,356,000 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $16,796,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $17,117,000 31 Dec 2020 10-K 14 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.